| Product NDC: | 66993-709 |
| Proprietary Name: | Mirtazapine |
| Non Proprietary Name: | Mirtazapine |
| Active Ingredient(s): | 15 mg/1 & nbsp; Mirtazapine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 66993-709 |
| Labeler Name: | Prasco Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021208 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20010112 |
| Package NDC: | 66993-709-30 |
| Package Description: | 5 BLISTER PACK in 1 BOX (66993-709-30) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| NDC Code | 66993-709-30 |
| Proprietary Name | Mirtazapine |
| Package Description | 5 BLISTER PACK in 1 BOX (66993-709-30) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| Product NDC | 66993-709 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mirtazapine |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20010112 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Prasco Laboratories |
| Substance Name | MIRTAZAPINE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |